
Curadh MTR and Alpha Fusion to Spotlight Breakthrough Cancer Therapy at Radiopharmaceutical Summit
CHESTER SPRINGS, PA — Curadh MTR Inc. and Alpha Fusion, Inc. are set to showcase advances in cancer treatment using Astatine-211 (At-211) radiopharmaceuticals at the upcoming 4th Targeted Radiopharmaceuticals Summit …
Curadh MTR and Alpha Fusion to Spotlight Breakthrough Cancer Therapy at Radiopharmaceutical Summit Read More